Statement Of Financial Position [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
33 083 BGN
35 319 BGN
Intangible assets other than goodwill
3 560 BGN
3 761 BGN
Cash and cash equivalents
73,000 BGN
142,000 BGN
57,000 BGN
Assets
122 499 BGN
119 861 BGN
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
84 500 BGN
84 500 BGN
Retained earnings
7 701 BGN
4 587 BGN
Equity attributable to owners of parent
105 001 BGN
101 585 BGN
Non-controlling interests
- BGN
- BGN
Equity
105 001 BGN
8 431 BGN
101 585 BGN
4 369 BGN
- BGN
7 701 BGN
84 500 BGN
105 001 BGN
8 147 BGN
4 587 BGN
101 585 BGN
4 351 BGN
101 585 BGN
- BGN
84 500 BGN
1 937 BGN
8 007 BGN
- BGN
98 819 BGN
84 500 BGN
4 375 BGN
98 819 BGN
Liabilities [abstract]
Deferred tax liabilities
1 113 BGN
1 042 BGN
Liabilities
17 498 BGN
18 276 BGN
Equity and liabilities
122 499 BGN
119 861 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.